Xiujuan Chang

Title: Innovator Xiujuan Chang: Pioneering Advances in Ginkgo Diterpene Lactone Composition

Introduction

Xiujuan Chang, an innovative inventor based in Jiangsu, China, has made significant contributions to the field of biochemistry and pharmaceuticals. With two patents to his name, Chang's work focuses on the development of Ginkgo diterpene lactone compositions that showcase notable therapeutic effects.

Latest Patents

Xiujuan Chang's latest patents include a groundbreaking Ginkgo diterpene lactone composition designed to address neurological and depressive conditions. The first patent outlines a composition that effectively lowers neurological function scores in cerebral ischemia-reperfusion rats, reduces cerebral ischemic areas, and diminishes brain tissue edema. Additionally, the composition demonstrates the capacity to inhibit rabbit platelet aggregation induced by PAF and ADP at various time points. Notably, the synergistic effects of each monomer compound within the diterpene lactone composition are highlighted, showcasing enhanced efficacy at specific ratios.

The second patent emphasizes the ability of the Ginkgo diterpene lactone composition to improve depressive states. Experiments reveal that the composition can prolong tail flick intervals and swimming intervals in mice, thereby indicating its positive influence on depressive symptoms. The inclusion of certain ginkgolides, specifically ginkgolide C, ginkgolide J, and ginkgolide L, significantly amplifies the therapeutic effects, leading to improved oxidative stress parameters such as SOD, MDA, GSH, and TAC.

Career Highlights

Xiujuan Chang is currently affiliated with Jiangsu Kanion Pharmaceutical Co., Ltd., where he continues to innovate and explore new advancements in pharmacological products. His dedication to research and development in the field of plant-based therapeutics has positioned him as a leading figure in his area of expertise.

Collaborations

Chang's innovative endeavors are further supported by a talented team of coworkers, including Wei Xiao and Enli Zhou. Their collaborative efforts have been integral to the success of the research projects undertaken at Jiangsu Kanion Pharmaceutical Co., Ltd.

Conclusion

Xiujuan Chang's commitment to discovering novel Ginkgo diterpene lactone compositions reflects his contributions to the pharmaceutical industry. His patents not only advance scientific understanding but also pave the way for potential therapeutic applications that can improve the quality of life for many individuals facing neurological and depressive challenges.